

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 7.19507668 |
| 2 | regulation of platelet aggregation (GO:0090330) | 6.84689756 |
| 3 | definitive hemopoiesis (GO:0060216) | 6.69729905 |
| 4 | positive regulation of megakaryocyte differentiation (GO:0045654) | 6.67133928 |
| 5 | thrombin receptor signaling pathway (GO:0070493) | 6.60540847 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 6.12743934 |
| 7 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 6.11836152 |
| 8 | regulation of platelet activation (GO:0010543) | 5.91600144 |
| 9 | megakaryocyte development (GO:0035855) | 5.88431073 |
| 10 | regulation of hypersensitivity (GO:0002883) | 5.58359576 |
| 11 | lipoxygenase pathway (GO:0019372) | 5.53059410 |
| 12 | positive regulation of mast cell degranulation (GO:0043306) | 5.43882036 |
| 13 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 5.43882036 |
| 14 | * platelet aggregation (GO:0070527) | 5.42318418 |
| 15 | angiotensin maturation (GO:0002003) | 4.99187805 |
| 16 | tyrosine phosphorylation of STAT protein (GO:0007260) | 4.90758584 |
| 17 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.90318927 |
| 18 | blood coagulation, intrinsic pathway (GO:0007597) | 4.84490108 |
| 19 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.81015581 |
| 20 | regulation of integrin activation (GO:0033623) | 4.79701128 |
| 21 | viral transcription (GO:0019083) | 4.76377251 |
| 22 | protein neddylation (GO:0045116) | 4.75791480 |
| 23 | platelet dense granule organization (GO:0060155) | 4.70549292 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.67994695 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.67994695 |
| 26 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.63642028 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 4.58735152 |
| 28 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.57733042 |
| 29 | DNA unwinding involved in DNA replication (GO:0006268) | 4.55821113 |
| 30 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.54525501 |
| 31 | translational termination (GO:0006415) | 4.54145009 |
| 32 | DNA strand elongation (GO:0022616) | 4.46748762 |
| 33 | positive regulation of mast cell activation (GO:0033005) | 4.46302868 |
| 34 | neutrophil activation (GO:0042119) | 4.35674843 |
| 35 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.34488117 |
| 36 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.22664283 |
| 37 | positive regulation of granulocyte differentiation (GO:0030854) | 4.11659554 |
| 38 | translational elongation (GO:0006414) | 4.11533149 |
| 39 | angiogenesis involved in wound healing (GO:0060055) | 4.10768534 |
| 40 | negative regulation of platelet activation (GO:0010544) | 4.07559339 |
| 41 | DNA replication initiation (GO:0006270) | 4.06851108 |
| 42 | negative regulation of phagocytosis (GO:0050765) | 4.06641485 |
| 43 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.01513046 |
| 44 | regulation of erythrocyte differentiation (GO:0045646) | 4.01118912 |
| 45 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.99205723 |
| 46 | mast cell degranulation (GO:0043303) | 3.97840639 |
| 47 | mast cell activation involved in immune response (GO:0002279) | 3.97840639 |
| 48 | embryonic hemopoiesis (GO:0035162) | 3.97417350 |
| 49 | actin nucleation (GO:0045010) | 3.95629669 |
| 50 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.94626859 |
| 51 | adenosine receptor signaling pathway (GO:0001973) | 3.93499131 |
| 52 | mast cell activation (GO:0045576) | 3.90700254 |
| 53 | cotranslational protein targeting to membrane (GO:0006613) | 3.89733354 |
| 54 | protein targeting to ER (GO:0045047) | 3.88756551 |
| 55 | * homotypic cell-cell adhesion (GO:0034109) | 3.88719715 |
| 56 | secretory granule organization (GO:0033363) | 3.85447762 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.80750024 |
| 58 | telomere maintenance via recombination (GO:0000722) | 3.78922894 |
| 59 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.78465982 |
| 60 | granulocyte activation (GO:0036230) | 3.78424378 |
| 61 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.77307462 |
| 62 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.76026396 |
| 63 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.71906820 |
| 64 | leukocyte degranulation (GO:0043299) | 3.68504701 |
| 65 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.64715911 |
| 66 | ribosomal small subunit biogenesis (GO:0042274) | 3.63453038 |
| 67 | protein localization to endoplasmic reticulum (GO:0070972) | 3.63417979 |
| 68 | positive regulation of erythrocyte differentiation (GO:0045648) | 3.60717043 |
| 69 | mitotic recombination (GO:0006312) | 3.59328296 |
| 70 | viral life cycle (GO:0019058) | 3.57594339 |
| 71 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.57512678 |
| 72 | leukotriene biosynthetic process (GO:0019370) | 3.57058798 |
| 73 | erythrocyte maturation (GO:0043249) | 3.54635079 |
| 74 | myeloid cell development (GO:0061515) | 3.54040429 |
| 75 | negative regulation of norepinephrine secretion (GO:0010700) | 3.53044782 |
| 76 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.52967525 |
| 77 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.52941270 |
| 78 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.52885999 |
| 79 | regulation of megakaryocyte differentiation (GO:0045652) | 3.52602364 |
| 80 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.51811357 |
| 81 | cellular protein complex disassembly (GO:0043624) | 3.49535457 |
| 82 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.49248051 |
| 83 | germ cell migration (GO:0008354) | 3.48615775 |
| 84 | positive regulation of leukocyte degranulation (GO:0043302) | 3.47573828 |
| 85 | granulocyte differentiation (GO:0030851) | 3.46234792 |
| 86 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.44027046 |
| 87 | maturation of SSU-rRNA (GO:0030490) | 3.43575659 |
| 88 | T cell homeostasis (GO:0043029) | 3.42691947 |
| 89 | endothelium development (GO:0003158) | 3.41425749 |
| 90 | * platelet activation (GO:0030168) | 3.39479516 |
| 91 | superoxide anion generation (GO:0042554) | 3.38303512 |
| 92 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.38238817 |
| 93 | histamine transport (GO:0051608) | 3.36829778 |
| 94 | regulation of mast cell activation (GO:0033003) | 3.33708024 |
| 95 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.32574563 |
| 96 | oxygen transport (GO:0015671) | 3.32099949 |
| 97 | purinergic receptor signaling pathway (GO:0035587) | 3.28326416 |
| 98 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.27697806 |
| 99 | polyamine biosynthetic process (GO:0006596) | 3.27222260 |
| 100 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.26469294 |
| 101 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.23032030 |
| 102 | translational initiation (GO:0006413) | 3.22203529 |
| 103 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.20956209 |
| 104 | monoamine transport (GO:0015844) | 3.20138169 |
| 105 | negative regulation of stress fiber assembly (GO:0051497) | 3.18877951 |
| 106 | telomere maintenance via telomere lengthening (GO:0010833) | 3.17337006 |
| 107 | toxin transport (GO:1901998) | 3.16911342 |
| 108 | regulation of endothelial cell differentiation (GO:0045601) | 3.16721707 |
| 109 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.16123586 |
| 110 | negative regulation of T cell apoptotic process (GO:0070233) | 3.15034361 |
| 111 | protein complex disassembly (GO:0043241) | 3.14919992 |
| 112 | negative regulation of heart rate (GO:0010459) | 3.14209215 |
| 113 | positive regulation of blood coagulation (GO:0030194) | 3.13193448 |
| 114 | positive regulation of hemostasis (GO:1900048) | 3.13193448 |
| 115 | protein localization to kinetochore (GO:0034501) | 3.11452964 |
| 116 | * platelet degranulation (GO:0002576) | 3.10756496 |
| 117 | regulation of mitochondrial depolarization (GO:0051900) | 3.09926787 |
| 118 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.09491242 |
| 119 | positive regulation of macrophage differentiation (GO:0045651) | 3.07928265 |
| 120 | regulation of leukocyte degranulation (GO:0043300) | 3.07596202 |
| 121 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.07051872 |
| 122 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.05450211 |
| 123 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.03298628 |
| 124 | cytokine production involved in immune response (GO:0002367) | 3.03016591 |
| 125 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.00603365 |
| 126 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.94700440 |
| 127 | DNA topological change (GO:0006265) | 2.93137668 |
| 128 | negative regulation of RNA splicing (GO:0033119) | 2.92293592 |
| 129 | autophagic vacuole fusion (GO:0000046) | 2.90308783 |
| 130 | macromolecular complex disassembly (GO:0032984) | 2.90196490 |
| 131 | platelet formation (GO:0030220) | 2.89371436 |
| 132 | heparin biosynthetic process (GO:0030210) | 2.89160260 |
| 133 | heparin metabolic process (GO:0030202) | 2.89160260 |
| 134 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.87407828 |
| 135 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.87397105 |
| 136 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.87286534 |
| 137 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.87286534 |
| 138 | modulation by symbiont of host immune response (GO:0052553) | 2.87286534 |
| 139 | positive regulation by symbiont of host defense response (GO:0052509) | 2.87286534 |
| 140 | modulation by symbiont of host defense response (GO:0052031) | 2.87286534 |
| 141 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.87286534 |
| 142 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.85763255 |
| 143 | DNA deamination (GO:0045006) | 2.85665998 |
| 144 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.84037185 |
| 145 | myeloid cell activation involved in immune response (GO:0002275) | 2.83575766 |
| 146 | cyclooxygenase pathway (GO:0019371) | 2.83099133 |
| 147 | response to host immune response (GO:0052572) | 2.83065938 |
| 148 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83065938 |
| 149 | regulation of DNA endoreduplication (GO:0032875) | 2.81805454 |
| 150 | protein localization to chromosome, centromeric region (GO:0071459) | 2.81109949 |
| 151 | regulation of gamma-delta T cell activation (GO:0046643) | 2.79739578 |
| 152 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.79521876 |
| 153 | lymphoid progenitor cell differentiation (GO:0002320) | 2.78929298 |
| 154 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.78011553 |
| 155 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.77703237 |
| 156 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.77318426 |
| 157 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.77093459 |
| 158 | translesion synthesis (GO:0019985) | 2.76519845 |
| 159 | regulation of granulocyte differentiation (GO:0030852) | 2.76037025 |
| 160 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.75635865 |
| 161 | positive regulation of coagulation (GO:0050820) | 2.75195707 |
| 162 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.73791748 |
| 163 | erythrocyte differentiation (GO:0030218) | 2.71821994 |
| 164 | regulation of B cell differentiation (GO:0045577) | 2.71548627 |
| 165 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.71286899 |
| 166 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.69645344 |
| 167 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.66727642 |
| 168 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.65662455 |
| 169 | mRNA catabolic process (GO:0006402) | 2.64019191 |
| 170 | erythrocyte development (GO:0048821) | 2.58046887 |
| 171 | regulation of necroptotic process (GO:0060544) | 2.57996223 |
| 172 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.57594199 |
| 173 | RNA catabolic process (GO:0006401) | 2.56580902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.76866399 |
| 2 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 4.46887214 |
| 3 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.37118380 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.89456614 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.73783775 |
| 6 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.44183489 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.07768593 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.96942950 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.91286228 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.89305213 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.88085939 |
| 12 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.84407656 |
| 13 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.75867705 |
| 14 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.66554689 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.58255847 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.50178540 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.49197047 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40978994 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.34778852 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32702226 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.26741749 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17216179 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.17124140 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.07185606 |
| 25 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.05308243 |
| 26 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.03933173 |
| 27 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.01311154 |
| 28 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96691895 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95821075 |
| 30 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.95206937 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94462518 |
| 32 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.86876379 |
| 33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.85714941 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.84463704 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.84335897 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83961672 |
| 37 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.77040481 |
| 38 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.73390201 |
| 39 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.71637389 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71005224 |
| 41 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.69684958 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68925592 |
| 43 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68271475 |
| 44 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.67522527 |
| 45 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.67498897 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.66806631 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.66781260 |
| 48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.66648150 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65984020 |
| 50 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.65934663 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62762816 |
| 52 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.62573132 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.62466582 |
| 54 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.60346783 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.55803740 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55313141 |
| 57 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.53503018 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52945771 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52505291 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.51870387 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49861274 |
| 62 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.47490053 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.47346606 |
| 64 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.46662288 |
| 65 | MYB_26560356_Chip-Seq_TH1_Human | 1.44987171 |
| 66 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.44278043 |
| 67 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.44045901 |
| 68 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.43781647 |
| 69 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40127214 |
| 70 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.39964139 |
| 71 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.39717713 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.38715689 |
| 73 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35789088 |
| 74 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.32702984 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31182323 |
| 76 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.29701123 |
| 77 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28769549 |
| 78 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28648391 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25481588 |
| 80 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.25165985 |
| 81 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24813679 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23350214 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22657367 |
| 84 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22348144 |
| 85 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21737570 |
| 86 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21262769 |
| 87 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.19686515 |
| 88 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.16722749 |
| 89 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15854503 |
| 90 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.14088689 |
| 91 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.13689113 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12208471 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12119448 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11807722 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11767790 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11753652 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11216370 |
| 98 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10015390 |
| 99 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.09959544 |
| 100 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.09877217 |
| 101 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.09684192 |
| 102 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.09308337 |
| 103 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.09223549 |
| 104 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.09185886 |
| 105 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08059997 |
| 106 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07563594 |
| 107 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07185218 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06814126 |
| 109 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06078932 |
| 110 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.05738032 |
| 111 | P300_27268052_Chip-Seq_Bcells_Human | 1.05165361 |
| 112 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03873861 |
| 113 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03800356 |
| 114 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.03768497 |
| 115 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.03649783 |
| 116 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02668937 |
| 117 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.02270754 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01852139 |
| 119 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00571908 |
| 120 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.00008855 |
| 121 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99279768 |
| 122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99112850 |
| 123 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98723195 |
| 124 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.98236842 |
| 125 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97525073 |
| 126 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97058478 |
| 127 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96970018 |
| 128 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96008811 |
| 129 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.95601158 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95321806 |
| 131 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94543867 |
| 132 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.94010450 |
| 133 | MAF_26560356_Chip-Seq_TH2_Human | 0.93881321 |
| 134 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93585546 |
| 135 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92069805 |
| 136 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91475385 |
| 137 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.90746932 |
| 138 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89458421 |
| 139 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.89280421 |
| 140 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.89218349 |
| 141 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88112018 |
| 142 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88059033 |
| 143 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.87788921 |
| 144 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82231992 |
| 145 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.81913426 |
| 146 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81667187 |
| 147 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.78298574 |
| 148 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.75205001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 4.58932240 |
| 2 | MP0002396_abnormal_hematopoietic_system | 4.40041512 |
| 3 | MP0004147_increased_porphyrin_level | 3.80234854 |
| 4 | * MP0005464_abnormal_platelet_physiology | 3.61316541 |
| 5 | MP0005397_hematopoietic_system_phenotyp | 3.46923706 |
| 6 | MP0001545_abnormal_hematopoietic_system | 3.46923706 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 3.24710067 |
| 8 | * MP0004808_abnormal_hematopoietic_stem | 3.03166903 |
| 9 | MP0005083_abnormal_biliary_tract | 2.95754584 |
| 10 | MP0005174_abnormal_tail_pigmentation | 2.92729910 |
| 11 | * MP0000465_gastrointestinal_hemorrhage | 2.65208461 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.45685656 |
| 13 | MP0009278_abnormal_bone_marrow | 2.45582779 |
| 14 | MP0003656_abnormal_erythrocyte_physiolo | 2.41718992 |
| 15 | * MP0002398_abnormal_bone_marrow | 2.38726530 |
| 16 | MP0008057_abnormal_DNA_replication | 2.34587636 |
| 17 | MP0003111_abnormal_nucleus_morphology | 2.28295312 |
| 18 | MP0005075_abnormal_melanosome_morpholog | 2.23784511 |
| 19 | MP0003693_abnormal_embryo_hatching | 2.18712270 |
| 20 | MP0005671_abnormal_response_to | 2.14462228 |
| 21 | MP0000490_abnormal_crypts_of | 2.12069159 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.00665621 |
| 23 | MP0003436_decreased_susceptibility_to | 1.95503431 |
| 24 | * MP0002722_abnormal_immune_system | 1.93602603 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.90746721 |
| 26 | MP0005167_abnormal_blood-brain_barrier | 1.86153301 |
| 27 | MP0005025_abnormal_response_to | 1.83337573 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.82129731 |
| 29 | MP0001851_eye_inflammation | 1.79476879 |
| 30 | MP0001819_abnormal_immune_cell | 1.79447244 |
| 31 | * MP0000689_abnormal_spleen_morphology | 1.79170282 |
| 32 | * MP0002429_abnormal_blood_cell | 1.78502650 |
| 33 | MP0003077_abnormal_cell_cycle | 1.75747828 |
| 34 | MP0001800_abnormal_humoral_immune | 1.75273235 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.74014298 |
| 36 | MP0002419_abnormal_innate_immunity | 1.72234680 |
| 37 | MP0000716_abnormal_immune_system | 1.71863796 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.71591594 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.69273287 |
| 40 | MP0006054_spinal_hemorrhage | 1.67266316 |
| 41 | MP0003724_increased_susceptibility_to | 1.65571415 |
| 42 | MP0002723_abnormal_immune_serum | 1.64846960 |
| 43 | MP0001853_heart_inflammation | 1.64471762 |
| 44 | MP0002095_abnormal_skin_pigmentation | 1.64400063 |
| 45 | MP0003303_peritoneal_inflammation | 1.62734169 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.59594623 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.57303347 |
| 48 | MP0000343_altered_response_to | 1.56893442 |
| 49 | MP0002736_abnormal_nociception_after | 1.54552299 |
| 50 | MP0009785_altered_susceptibility_to | 1.50585198 |
| 51 | MP0002405_respiratory_system_inflammati | 1.49415863 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.47835016 |
| 53 | MP0000230_abnormal_systemic_arterial | 1.47655647 |
| 54 | MP0005410_abnormal_fertilization | 1.47428568 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.46841123 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.45179804 |
| 57 | MP0004510_myositis | 1.43993366 |
| 58 | MP0002733_abnormal_thermal_nociception | 1.43463198 |
| 59 | MP0008007_abnormal_cellular_replicative | 1.43427654 |
| 60 | MP0001790_abnormal_immune_system | 1.42554254 |
| 61 | MP0005387_immune_system_phenotype | 1.42554254 |
| 62 | MP0003866_abnormal_defecation | 1.41493936 |
| 63 | MP0001986_abnormal_taste_sensitivity | 1.39301290 |
| 64 | MP0010307_abnormal_tumor_latency | 1.37652237 |
| 65 | MP0001188_hyperpigmentation | 1.37516821 |
| 66 | MP0001873_stomach_inflammation | 1.35159317 |
| 67 | MP0005646_abnormal_pituitary_gland | 1.34930241 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.33302432 |
| 69 | MP0000685_abnormal_immune_system | 1.32186525 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 1.30379420 |
| 71 | MP0008872_abnormal_physiological_respon | 1.26538982 |
| 72 | MP0004957_abnormal_blastocyst_morpholog | 1.25618153 |
| 73 | MP0003638_abnormal_response/metabolism_ | 1.25218146 |
| 74 | MP0002019_abnormal_tumor_incidence | 1.22732919 |
| 75 | MP0003943_abnormal_hepatobiliary_system | 1.18503716 |
| 76 | MP0001845_abnormal_inflammatory_respons | 1.16471191 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 1.16084678 |
| 78 | MP0002132_abnormal_respiratory_system | 1.14790800 |
| 79 | MP0001968_abnormal_touch/_nociception | 1.13409335 |
| 80 | MP0000015_abnormal_ear_pigmentation | 1.12880993 |
| 81 | MP0002166_altered_tumor_susceptibility | 1.12338898 |
| 82 | MP0008469_abnormal_protein_level | 1.12283856 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 1.11950122 |
| 84 | MP0000313_abnormal_cell_death | 1.10782283 |
| 85 | MP0008874_decreased_physiological_sensi | 1.08803077 |
| 86 | MP0004084_abnormal_cardiac_muscle | 1.05932374 |
| 87 | MP0003718_maternal_effect | 0.97950006 |
| 88 | MP0008770_decreased_survivor_rate | 0.97933969 |
| 89 | MP0008058_abnormal_DNA_repair | 0.96678710 |
| 90 | MP0005535_abnormal_body_temperature | 0.95573830 |
| 91 | MP0001533_abnormal_skeleton_physiology | 0.92386890 |
| 92 | MP0004130_abnormal_muscle_cell | 0.90648897 |
| 93 | MP0008873_increased_physiological_sensi | 0.90070971 |
| 94 | MP0008260_abnormal_autophagy | 0.89927357 |
| 95 | MP0009763_increased_sensitivity_to | 0.88414492 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.87797831 |
| 97 | * MP0009642_abnormal_blood_homeostasis | 0.87324614 |
| 98 | MP0001915_intracranial_hemorrhage | 0.86522690 |
| 99 | MP0002006_tumorigenesis | 0.86102262 |
| 100 | MP0000858_altered_metastatic_potential | 0.85278044 |
| 101 | MP0002735_abnormal_chemical_nociception | 0.85088386 |
| 102 | MP0005636_abnormal_mineral_homeostasis | 0.82172534 |
| 103 | MP0005381_digestive/alimentary_phenotyp | 0.82152739 |
| 104 | MP0001970_abnormal_pain_threshold | 0.81831774 |
| 105 | MP0009764_decreased_sensitivity_to | 0.81675543 |
| 106 | MP0001663_abnormal_digestive_system | 0.80168810 |
| 107 | MP0010368_abnormal_lymphatic_system | 0.79433307 |
| 108 | MP0002938_white_spotting | 0.77736324 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.77489077 |
| 110 | MP0008932_abnormal_embryonic_tissue | 0.77336116 |
| 111 | MP0009379_abnormal_foot_pigmentation | 0.77229683 |
| 112 | MP0000598_abnormal_liver_morphology | 0.76803818 |
| 113 | MP0003828_pulmonary_edema | 0.76316701 |
| 114 | MP0000350_abnormal_cell_proliferation | 0.73524612 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.72877184 |
| 116 | MP0004036_abnormal_muscle_relaxation | 0.72261690 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.71930373 |
| 118 | MP0010329_abnormal_lipoprotein_level | 0.70500018 |
| 119 | MP0000249_abnormal_blood_vessel | 0.69993407 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.69944407 |
| 121 | MP0009840_abnormal_foam_cell | 0.69807711 |
| 122 | MP0000358_abnormal_cell_content/ | 0.68822327 |
| 123 | MP0008775_abnormal_heart_ventricle | 0.68383210 |
| 124 | MP0006082_CNS_inflammation | 0.68108457 |
| 125 | MP0004947_skin_inflammation | 0.67076222 |
| 126 | MP0000477_abnormal_intestine_morphology | 0.65881394 |
| 127 | MP0002118_abnormal_lipid_homeostasis | 0.63636711 |
| 128 | MP0003186_abnormal_redox_activity | 0.62995340 |
| 129 | * MP0002086_abnormal_extraembryonic_tissu | 0.62981339 |
| 130 | MP0005647_abnormal_sex_gland | 0.62156561 |
| 131 | MP0003075_altered_response_to | 0.62012161 |
| 132 | MP0003183_abnormal_peptide_metabolism | 0.61283485 |
| 133 | MP0002080_prenatal_lethality | 0.60893304 |
| 134 | MP0001664_abnormal_digestion | 0.60855314 |
| 135 | MP0009931_abnormal_skin_appearance | 0.59773461 |
| 136 | MP0006276_abnormal_autonomic_nervous | 0.58597149 |
| 137 | MP0003879_abnormal_hair_cell | 0.58083426 |
| 138 | MP0005165_increased_susceptibility_to | 0.57423140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Prolonged bleeding time (HP:0003010) | 7.58529912 |
| 2 | * Petechiae (HP:0000967) | 7.21906904 |
| 3 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.55433699 |
| 4 | Abnormal number of erythroid precursors (HP:0012131) | 5.50170270 |
| 5 | * Abnormal platelet volume (HP:0011876) | 5.45611428 |
| 6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.41088973 |
| 7 | * Purpura (HP:0000979) | 5.33067928 |
| 8 | Chronic otitis media (HP:0000389) | 5.16044444 |
| 9 | * Increased mean platelet volume (HP:0011877) | 5.06707377 |
| 10 | Aplastic anemia (HP:0001915) | 4.93195009 |
| 11 | * Menorrhagia (HP:0000132) | 4.83850494 |
| 12 | * Epistaxis (HP:0000421) | 4.70830900 |
| 13 | * Impaired platelet aggregation (HP:0003540) | 4.52453763 |
| 14 | * Abnormal platelet function (HP:0011869) | 4.52453763 |
| 15 | Thrombocytosis (HP:0001894) | 4.17998011 |
| 16 | Hyperthyroidism (HP:0000836) | 4.11221682 |
| 17 | Poikilocytosis (HP:0004447) | 3.92734446 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 3.87555225 |
| 19 | IgM deficiency (HP:0002850) | 3.78462182 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.76667261 |
| 21 | Obstructive lung disease (HP:0006536) | 3.76667261 |
| 22 | Reticulocytopenia (HP:0001896) | 3.69729193 |
| 23 | Pallor (HP:0000980) | 3.56079919 |
| 24 | Stomatitis (HP:0010280) | 3.45082720 |
| 25 | * Gingival bleeding (HP:0000225) | 3.29694636 |
| 26 | Recurrent viral infections (HP:0004429) | 3.19480475 |
| 27 | Cellulitis (HP:0100658) | 3.17689888 |
| 28 | Papilledema (HP:0001085) | 3.15600189 |
| 29 | Acute myeloid leukemia (HP:0004808) | 3.11140088 |
| 30 | Acanthocytosis (HP:0001927) | 3.02700842 |
| 31 | Panhypogammaglobulinemia (HP:0003139) | 2.96379026 |
| 32 | Abnormality of macrophages (HP:0004311) | 2.94774079 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.91389979 |
| 34 | Abnormal pupillary function (HP:0007686) | 2.91219841 |
| 35 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.89694407 |
| 36 | Myelodysplasia (HP:0002863) | 2.87481938 |
| 37 | Recurrent abscess formation (HP:0002722) | 2.86929988 |
| 38 | Hepatosplenomegaly (HP:0001433) | 2.84554081 |
| 39 | Nasal polyposis (HP:0100582) | 2.83602350 |
| 40 | Abnormality of the nasal mucosa (HP:0000433) | 2.80729384 |
| 41 | Esophageal neoplasm (HP:0100751) | 2.80254079 |
| 42 | Neoplasm of head and neck (HP:0012288) | 2.80254079 |
| 43 | Paralysis (HP:0003470) | 2.77387927 |
| 44 | Macrocytic anemia (HP:0001972) | 2.72566191 |
| 45 | Abnormality of reticulocytes (HP:0004312) | 2.71400481 |
| 46 | Abnormality of lateral ventricle (HP:0030047) | 2.71243681 |
| 47 | Recurrent bacterial skin infections (HP:0005406) | 2.70921866 |
| 48 | Episodic fever (HP:0001954) | 2.67206664 |
| 49 | Conjunctival telangiectasia (HP:0000524) | 2.64889272 |
| 50 | Seborrheic dermatitis (HP:0001051) | 2.60856388 |
| 51 | Recurrent fungal infections (HP:0002841) | 2.59075904 |
| 52 | Hypochromic anemia (HP:0001931) | 2.56592206 |
| 53 | Abnormality of the common coagulation pathway (HP:0010990) | 2.52730255 |
| 54 | Increased IgM level (HP:0003496) | 2.51368641 |
| 55 | Dyschromatopsia (HP:0007641) | 2.50794173 |
| 56 | Hypertensive crisis (HP:0100735) | 2.48914057 |
| 57 | Acute lymphatic leukemia (HP:0006721) | 2.47939746 |
| 58 | Abnormality of the prostate (HP:0008775) | 2.47677935 |
| 59 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.47201918 |
| 60 | Muscle fiber atrophy (HP:0100295) | 2.44640137 |
| 61 | Patchy hypopigmentation of hair (HP:0011365) | 2.44099421 |
| 62 | Truncus arteriosus (HP:0001660) | 2.39854252 |
| 63 | 11 pairs of ribs (HP:0000878) | 2.34349862 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.33883913 |
| 65 | Eczematoid dermatitis (HP:0000976) | 2.33619063 |
| 66 | Microcytic anemia (HP:0001935) | 2.29981175 |
| 67 | Arterial thrombosis (HP:0004420) | 2.29635561 |
| 68 | White forelock (HP:0002211) | 2.28393719 |
| 69 | Asplenia (HP:0001746) | 2.23085904 |
| 70 | Hyperacusis (HP:0010780) | 2.21579602 |
| 71 | Reduced antithrombin III activity (HP:0001976) | 2.20663121 |
| 72 | Cutaneous melanoma (HP:0012056) | 2.19652525 |
| 73 | Albinism (HP:0001022) | 2.19575685 |
| 74 | Type 2 muscle fiber atrophy (HP:0003554) | 2.17367178 |
| 75 | Reticulocytosis (HP:0001923) | 2.16090581 |
| 76 | Tinnitus (HP:0000360) | 2.14433096 |
| 77 | Gastrointestinal inflammation (HP:0004386) | 2.12854898 |
| 78 | Inflammation of the large intestine (HP:0002037) | 2.10606926 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 2.10526366 |
| 80 | Heterochromia iridis (HP:0001100) | 2.10521248 |
| 81 | Joint swelling (HP:0001386) | 2.09713277 |
| 82 | Spontaneous hematomas (HP:0007420) | 2.07284956 |
| 83 | Chest pain (HP:0100749) | 2.06080913 |
| 84 | Lymphoma (HP:0002665) | 2.04606604 |
| 85 | Encephalitis (HP:0002383) | 2.03358951 |
| 86 | Recurrent bronchitis (HP:0002837) | 2.02636400 |
| 87 | * Bruising susceptibility (HP:0000978) | 2.02303017 |
| 88 | Abnormality of the fingertips (HP:0001211) | 2.00256290 |
| 89 | Bone marrow hypocellularity (HP:0005528) | 1.98656269 |
| 90 | Amaurosis fugax (HP:0100576) | 1.98364572 |
| 91 | Vertigo (HP:0002321) | 1.98359770 |
| 92 | Slender long bone (HP:0003100) | 1.97890079 |
| 93 | Increased serum ferritin (HP:0003281) | 1.97530796 |
| 94 | Birth length less than 3rd percentile (HP:0003561) | 1.97162893 |
| 95 | Granulocytopenia (HP:0001913) | 1.96765194 |
| 96 | Urticaria (HP:0001025) | 1.96681392 |
| 97 | Increased density of long bones (HP:0006392) | 1.95991180 |
| 98 | Type I transferrin isoform profile (HP:0003642) | 1.93947932 |
| 99 | Pancytopenia (HP:0001876) | 1.92369381 |
| 100 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.92197984 |
| 101 | Recurrent skin infections (HP:0001581) | 1.89819372 |
| 102 | Abnormal large intestine physiology (HP:0012700) | 1.86425386 |
| 103 | Interstitial pulmonary disease (HP:0006530) | 1.85292207 |
| 104 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.85051633 |
| 105 | Neutropenia (HP:0001875) | 1.82399536 |
| 106 | Viral hepatitis (HP:0006562) | 1.81152668 |
| 107 | Meningitis (HP:0001287) | 1.81031893 |
| 108 | Hyperbilirubinemia (HP:0002904) | 1.79611668 |
| 109 | Thrombophlebitis (HP:0004418) | 1.79270374 |
| 110 | Polycythemia (HP:0001901) | 1.78698774 |
| 111 | Broad palm (HP:0001169) | 1.78132691 |
| 112 | Myositis (HP:0100614) | 1.77739616 |
| 113 | Hypochromic microcytic anemia (HP:0004840) | 1.76170507 |
| 114 | Leukocytosis (HP:0001974) | 1.76074249 |
| 115 | Spontaneous abortion (HP:0005268) | 1.75997473 |
| 116 | Erythema (HP:0010783) | 1.75302595 |
| 117 | Increased IgE level (HP:0003212) | 1.74755954 |
| 118 | Agammaglobulinemia (HP:0004432) | 1.73356703 |
| 119 | High pitched voice (HP:0001620) | 1.73207540 |
| 120 | Hypoparathyroidism (HP:0000829) | 1.72696861 |
| 121 | Abnormality of T cells (HP:0002843) | 1.71645192 |
| 122 | Ventricular fibrillation (HP:0001663) | 1.71141119 |
| 123 | Easy fatigability (HP:0003388) | 1.70457550 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 1.70124970 |
| 125 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.70122890 |
| 126 | Recurrent cutaneous fungal infections (HP:0011370) | 1.70122890 |
| 127 | Hypoplasia of the thymus (HP:0000778) | 1.70087780 |
| 128 | Migraine (HP:0002076) | 1.69877875 |
| 129 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.69445913 |
| 130 | Visual hallucinations (HP:0002367) | 1.68956903 |
| 131 | Short middle phalanx of the 5th finger (HP:0004220) | 1.67554563 |
| 132 | Thoracic kyphosis (HP:0002942) | 1.66979172 |
| 133 | Generalized aminoaciduria (HP:0002909) | 1.66425221 |
| 134 | Severe visual impairment (HP:0001141) | 1.65846568 |
| 135 | Colitis (HP:0002583) | 1.65703946 |
| 136 | Upper limb muscle weakness (HP:0003484) | 1.63957138 |
| 137 | Atelectasis (HP:0100750) | 1.63677595 |
| 138 | Abnormality of iron homeostasis (HP:0011031) | 1.62885641 |
| 139 | Bowel incontinence (HP:0002607) | 1.58887843 |
| 140 | Joint hemorrhage (HP:0005261) | 1.58120319 |
| 141 | Decreased central vision (HP:0007663) | 1.55989151 |
| 142 | Abnormal hemoglobin (HP:0011902) | 1.55706448 |
| 143 | Splenomegaly (HP:0001744) | 1.52598606 |
| 144 | Dysautonomia (HP:0002459) | 1.51766935 |
| 145 | Exertional dyspnea (HP:0002875) | 1.50152075 |
| 146 | Nausea (HP:0002018) | 1.49134773 |
| 147 | Cerebral palsy (HP:0100021) | 1.49020025 |
| 148 | Male infertility (HP:0003251) | 1.44469648 |
| 149 | Hypertriglyceridemia (HP:0002155) | 1.43404142 |
| 150 | Cerebral ischemia (HP:0002637) | 1.40162814 |
| 151 | Muscle fibrillation (HP:0010546) | 1.38335571 |
| 152 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.37363577 |
| 153 | Gastrointestinal infarctions (HP:0005244) | 1.36861759 |
| 154 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.36367155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.29202723 |
| 2 | EEF2K | 5.17247417 |
| 3 | KIT | 3.77335258 |
| 4 | BMX | 3.33201308 |
| 5 | TIE1 | 2.89652826 |
| 6 | PIM2 | 2.86979924 |
| 7 | MAP4K1 | 2.68785189 |
| 8 | MATK | 2.68358527 |
| 9 | MST4 | 2.54057671 |
| 10 | NME2 | 2.52547404 |
| 11 | CDC7 | 2.33223813 |
| 12 | TAOK3 | 2.32807840 |
| 13 | BTK | 2.20491672 |
| 14 | STK16 | 2.14443855 |
| 15 | TEC | 1.94308852 |
| 16 | RPS6KB2 | 1.93570211 |
| 17 | PTK2B | 1.88438680 |
| 18 | MAPKAPK5 | 1.87907986 |
| 19 | NEK2 | 1.85788702 |
| 20 | WEE1 | 1.82020311 |
| 21 | MYLK | 1.65052320 |
| 22 | VRK1 | 1.63963039 |
| 23 | PKN2 | 1.60355700 |
| 24 | NUAK1 | 1.60333253 |
| 25 | TAOK2 | 1.56354342 |
| 26 | KDR | 1.55167535 |
| 27 | PIM1 | 1.52375914 |
| 28 | TESK2 | 1.47128928 |
| 29 | MAPKAPK3 | 1.46393996 |
| 30 | TXK | 1.45759680 |
| 31 | GRK5 | 1.43301800 |
| 32 | MAP2K3 | 1.42679095 |
| 33 | TRIB3 | 1.41644521 |
| 34 | FGR | 1.41307885 |
| 35 | TNIK | 1.34543479 |
| 36 | TGFBR1 | 1.33591566 |
| 37 | SYK | 1.32668181 |
| 38 | MKNK1 | 1.32489245 |
| 39 | SCYL2 | 1.29118061 |
| 40 | BUB1 | 1.26371622 |
| 41 | ZAP70 | 1.25752516 |
| 42 | BMPR2 | 1.23587877 |
| 43 | JAK3 | 1.21660444 |
| 44 | TRPM7 | 1.20905337 |
| 45 | TYK2 | 1.20210727 |
| 46 | ADRBK2 | 1.18898924 |
| 47 | FES | 1.17406599 |
| 48 | CDK4 | 1.14772275 |
| 49 | GRK6 | 1.09196829 |
| 50 | CLK1 | 1.07891137 |
| 51 | CDK6 | 1.07879957 |
| 52 | TAOK1 | 1.07568125 |
| 53 | CCNB1 | 1.07509967 |
| 54 | LRRK2 | 1.05391493 |
| 55 | CSK | 1.01738479 |
| 56 | LYN | 1.00053147 |
| 57 | BLK | 0.98908025 |
| 58 | CDK7 | 0.97674123 |
| 59 | VRK2 | 0.96953867 |
| 60 | ATR | 0.94205290 |
| 61 | MAP3K12 | 0.94133839 |
| 62 | PASK | 0.92380896 |
| 63 | TSSK6 | 0.91842201 |
| 64 | MAP3K3 | 0.91790248 |
| 65 | PAK1 | 0.91591275 |
| 66 | DYRK3 | 0.89467646 |
| 67 | STK4 | 0.88772022 |
| 68 | CDK19 | 0.88425732 |
| 69 | MAP3K11 | 0.87963884 |
| 70 | MAP3K5 | 0.86317937 |
| 71 | MAPK11 | 0.86222392 |
| 72 | MARK3 | 0.80711776 |
| 73 | TNK2 | 0.76111101 |
| 74 | MAP4K2 | 0.75547541 |
| 75 | PIK3CG | 0.75323425 |
| 76 | TBK1 | 0.74963739 |
| 77 | JAK2 | 0.74823845 |
| 78 | ADRBK1 | 0.73035950 |
| 79 | TGFBR2 | 0.72882695 |
| 80 | PRKCQ | 0.72699822 |
| 81 | IRAK3 | 0.72015972 |
| 82 | DAPK3 | 0.71829327 |
| 83 | BRSK2 | 0.71772985 |
| 84 | EIF2AK1 | 0.69442387 |
| 85 | TLK1 | 0.68928287 |
| 86 | PAK4 | 0.67583995 |
| 87 | ARAF | 0.66896040 |
| 88 | IRAK4 | 0.66534536 |
| 89 | BCKDK | 0.66244120 |
| 90 | PLK2 | 0.65197127 |
| 91 | HCK | 0.63887338 |
| 92 | ITK | 0.63645054 |
| 93 | STK10 | 0.62958773 |
| 94 | IKBKB | 0.62644176 |
| 95 | MAPK12 | 0.61498114 |
| 96 | ALK | 0.61362863 |
| 97 | LCK | 0.60807097 |
| 98 | PDK1 | 0.60628191 |
| 99 | SIK3 | 0.59822496 |
| 100 | RET | 0.59562727 |
| 101 | MAP3K10 | 0.58699499 |
| 102 | MAP3K1 | 0.58509588 |
| 103 | PTK6 | 0.56928367 |
| 104 | FLT3 | 0.56384160 |
| 105 | ILK | 0.56301248 |
| 106 | AURKB | 0.56076921 |
| 107 | TTK | 0.55336767 |
| 108 | MAPK4 | 0.54362383 |
| 109 | MAP3K8 | 0.54114942 |
| 110 | MUSK | 0.53971101 |
| 111 | MKNK2 | 0.52939061 |
| 112 | PAK2 | 0.52475442 |
| 113 | PRKD1 | 0.51502259 |
| 114 | MAPKAPK2 | 0.49742773 |
| 115 | PKN1 | 0.49641509 |
| 116 | RAF1 | 0.49350562 |
| 117 | PRKACG | 0.49196828 |
| 118 | DAPK1 | 0.48952954 |
| 119 | SRPK1 | 0.48549209 |
| 120 | HIPK2 | 0.48285747 |
| 121 | DAPK2 | 0.48184905 |
| 122 | PDPK1 | 0.47269229 |
| 123 | PRKCD | 0.47249867 |
| 124 | CDK8 | 0.46212277 |
| 125 | ZAK | 0.45264922 |
| 126 | BRSK1 | 0.45154263 |
| 127 | CSF1R | 0.44012935 |
| 128 | PRKG2 | 0.43960923 |
| 129 | RPS6KA6 | 0.43568404 |
| 130 | JAK1 | 0.43508152 |
| 131 | RPS6KA4 | 0.43325557 |
| 132 | MAP3K6 | 0.41993499 |
| 133 | FYN | 0.40800065 |
| 134 | MAP3K7 | 0.40375320 |
| 135 | ERBB2 | 0.40207325 |
| 136 | IRAK1 | 0.38980442 |
| 137 | YES1 | 0.38606606 |
| 138 | PLK4 | 0.38413851 |
| 139 | NEK1 | 0.37847773 |
| 140 | STK3 | 0.37416656 |
| 141 | SIK2 | 0.36943836 |
| 142 | IKBKE | 0.36703279 |
| 143 | PRPF4B | 0.36495980 |
| 144 | RPS6KA2 | 0.36373662 |
| 145 | RPS6KC1 | 0.36322784 |
| 146 | ACVR1B | 0.35124191 |
| 147 | BMPR1B | 0.32457877 |
| 148 | MAPK3 | 0.32199147 |
| 149 | MAPK13 | 0.31926505 |
| 150 | MAP2K1 | 0.30286315 |
| 151 | DYRK2 | 0.30046781 |
| 152 | EPHA3 | 0.29510376 |
| 153 | LMTK2 | 0.27555453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.68892024 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.81604291 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.51300726 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.40001989 |
| 5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.26124746 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.73921958 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.59693996 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.55441071 |
| 9 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.50249443 |
| 10 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.41505300 |
| 11 | * Platelet activation_Homo sapiens_hsa04611 | 2.15764248 |
| 12 | Cell cycle_Homo sapiens_hsa04110 | 2.07022038 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.02455562 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 1.98136594 |
| 15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.90145006 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.72830817 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.70963532 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.66787914 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.66327498 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.50765940 |
| 21 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.49603493 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.48904808 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.48123416 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.39211611 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.29470295 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29342959 |
| 27 | Endocytosis_Homo sapiens_hsa04144 | 1.29250808 |
| 28 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.28785255 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28026374 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.27244485 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.26085233 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.24537164 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.22974168 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.21454473 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20975610 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19989922 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19902120 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.18445280 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.17423440 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.15452940 |
| 41 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.13452189 |
| 42 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.11323894 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.11043858 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10983400 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07864383 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.07260706 |
| 47 | RNA transport_Homo sapiens_hsa03013 | 1.07163727 |
| 48 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.07014204 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.06557521 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04824384 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.04494306 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.03605140 |
| 53 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.00662098 |
| 54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.00037534 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98247234 |
| 56 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.97123655 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96743738 |
| 58 | RNA polymerase_Homo sapiens_hsa03020 | 0.96597831 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96202898 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94095848 |
| 61 | Gap junction_Homo sapiens_hsa04540 | 0.93950648 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92410154 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.91337756 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.90831442 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90299730 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89092265 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88806065 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87142698 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86780793 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.85277302 |
| 71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83748244 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81941862 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.81759406 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81137439 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81087995 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80674483 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.80108839 |
| 78 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77015871 |
| 79 | RNA degradation_Homo sapiens_hsa03018 | 0.75874916 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75551609 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74117903 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73330270 |
| 83 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69126279 |
| 84 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.68038043 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.67858884 |
| 86 | Salmonella infection_Homo sapiens_hsa05132 | 0.66470251 |
| 87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62805130 |
| 88 | Long-term depression_Homo sapiens_hsa04730 | 0.62423533 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61747316 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61147158 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60581534 |
| 92 | Proteasome_Homo sapiens_hsa03050 | 0.58917235 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.58593632 |
| 94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58312872 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57730940 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55602442 |
| 97 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.54248576 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53141703 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53136401 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52652766 |
| 101 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51666139 |
| 102 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.49446833 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.47662920 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47570368 |
| 105 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47414075 |
| 106 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46874836 |
| 107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46482722 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46215991 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.44768203 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.44676575 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44479918 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43726503 |
| 113 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43686943 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43183193 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42680739 |
| 116 | Pertussis_Homo sapiens_hsa05133 | 0.42525800 |
| 117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.41828120 |
| 118 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41544423 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41466008 |
| 120 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41118066 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40704878 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40124643 |
| 123 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39688610 |
| 124 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39645280 |
| 125 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39141228 |
| 126 | Malaria_Homo sapiens_hsa05144 | 0.35776174 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35291383 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35168095 |
| 129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35158358 |
| 130 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.34331202 |
| 131 | Morphine addiction_Homo sapiens_hsa05032 | 0.34012753 |
| 132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33525345 |
| 133 | Phototransduction_Homo sapiens_hsa04744 | 0.33427727 |
| 134 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33176980 |
| 135 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32306834 |
| 136 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.30517724 |
| 137 | Protein export_Homo sapiens_hsa03060 | 0.29864989 |
| 138 | Tuberculosis_Homo sapiens_hsa05152 | 0.28496427 |
| 139 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28260300 |
| 140 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.27427940 |
| 141 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27146685 |
| 142 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26956305 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24665152 |
| 144 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23296099 |
| 145 | Basal transcription factors_Homo sapiens_hsa03022 | 0.22383159 |
| 146 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.21553301 |
| 147 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20882437 |
| 148 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.19353032 |

